Abbott Laboratories SEC filings ABT

Abbott Laboratories has 1,001 filings in SEC EDGAR's recent list, going back to Jul 12, 2018. Its latest annual report, Form ARS, was filed on Mar 13, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 21, 2026 (other events). The company's fiscal year ends on December 31.

Abbott Laboratories SEC filings
Form Description Filed Period
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Oct 2, 2026 Sep 30, 2026
4 Insider transaction Sep 25, 2026 Sep 23, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
4 Insider transaction Sep 3, 2026 Sep 1, 2026
144 Notice of proposed sale Sep 2, 2026 —
4 Insider transaction Aug 27, 2026 Aug 25, 2026
144 Notice of proposed sale Aug 25, 2026 —
4 Insider transaction Aug 13, 2026 Aug 11, 2026
144 Notice of proposed sale Aug 11, 2026 —
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jul 1, 2026 Jun 30, 2026
4 Insider transaction Jun 29, 2026 Jun 27, 2026
4 Insider transaction Jun 18, 2026 May 7, 2026
144 Notice of proposed sale May 15, 2026 —
4 Insider transaction Apr 29, 2026 Apr 28, 2026
SCHEDULE 13G Ownership over 5% (passive) Apr 29, 2026 —
4 Insider transaction Apr 28, 2026 Apr 24, 2026
3 Initial insider ownership Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
4 Insider transaction Apr 28, 2026 Apr 24, 2026
144 Notice of proposed sale Apr 27, 2026 —
4 Insider transaction Apr 27, 2026 Apr 23, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 25, 2026 Mar 23, 2026
3 Initial insider ownership Mar 25, 2026 Mar 23, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 26, 2026 Feb 24, 2026
4 Insider transaction Feb 6, 2026 Feb 4, 2026
4 Insider transaction Jan 26, 2026 Jan 23, 2026
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
4 Insider transaction Jan 5, 2026 Dec 31, 2025
3 Initial insider ownership Dec 23, 2025 Dec 12, 2025
3 Initial insider ownership Dec 19, 2025 Dec 12, 2025
4 Insider transaction Dec 12, 2025 Dec 11, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Dec 3, 2025 —
4 Insider transaction Nov 25, 2025 Nov 25, 2025
144 Notice of proposed sale Nov 25, 2025 —
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Oct 2, 2025 Sep 30, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Sep 3, 2025 Sep 1, 2025
4 Insider transaction Aug 11, 2025 Aug 8, 2025
144 Notice of proposed sale Aug 8, 2025 —
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 30, 2025
4 Insider transaction Jul 1, 2025 Jun 27, 2025
3 Initial insider ownership Jul 1, 2025 Jun 27, 2025
4 Insider transaction May 2, 2025 Apr 30, 2025
144 Notice of proposed sale Apr 30, 2025 —
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 29, 2025 Apr 25, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Mar 7, 2025 Mar 6, 2025
144 Notice of proposed sale Mar 7, 2025 —
144 Notice of proposed sale Mar 6, 2025 —
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Mar 3, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
144 Notice of proposed sale Mar 3, 2025 —
3 Initial insider ownership Mar 3, 2025 Mar 1, 2025
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
144 Notice of proposed sale Mar 3, 2025 —
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 27, 2025 Feb 25, 2025
4 Insider transaction Feb 7, 2025 Feb 5, 2025
144 Notice of proposed sale Feb 5, 2025 —
4 Insider transaction Jan 31, 2025 Jan 29, 2025
4 Insider transaction Jan 31, 2025 Jan 30, 2025
4 Insider transaction Jan 30, 2025 Jan 28, 2025
144 Notice of proposed sale Jan 30, 2025 —
144 Notice of proposed sale Jan 30, 2025 —
144 Notice of proposed sale Jan 29, 2025 —
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
4 Insider transaction Jan 3, 2025 Dec 31, 2024
144 Notice of proposed sale Nov 4, 2024 —
4 Insider transaction Oct 23, 2024 Oct 21, 2024
144 Notice of proposed sale Oct 21, 2024 —
4 Insider transaction Oct 1, 2024 Sep 30, 2024
4 Insider transaction Oct 1, 2024 Sep 30, 2024
4 Insider transaction Oct 1, 2024 Sep 30, 2024
4 Insider transaction Oct 1, 2024 Sep 30, 2024
4 Insider transaction Sep 13, 2024 Sep 12, 2024
144 Notice of proposed sale Sep 12, 2024 —
4 Insider transaction Sep 4, 2024 Sep 1, 2024
4 Insider transaction Sep 4, 2024 Sep 1, 2024
144 Notice of proposed sale Sep 4, 2024 —
4 Insider transaction Jul 2, 2024 Jun 30, 2024
4 Insider transaction Jul 2, 2024 Jun 30, 2024
4 Insider transaction Jul 2, 2024 Jun 30, 2024
4 Insider transaction Jul 2, 2024 Jun 30, 2024
4 Insider transaction Jul 2, 2024 Jun 30, 2024
4 Insider transaction May 14, 2024 May 10, 2024
144 Notice of proposed sale May 10, 2024 —
4 Insider transaction May 8, 2024 May 7, 2024
144 Notice of proposed sale May 7, 2024 —
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 30, 2024 Apr 26, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024
4 Insider transaction Mar 4, 2024 Feb 29, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ABT (NYSE)
Fiscal year ends
December 31
Incorporated in
IL
Headquarters
Abbott Park, IL
SEC filer status
Large accelerated filer
SEC CIK
1800

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.